GEIST:UPC Searchengine

UPC_CFI_1/2023

Sanofi-Aventis Deutschland GmbH v. Amgen, Inc.

Datum
2024-01-24
Kammer
Munich (DE) Central Division - Section
Verfahrensart
Revocation Action
Sprache
EN

Metadaten

Fall-IDUPC_CFI_1-2023-eb342b319d79
Aktenzeichen
RegisterzeichenUPC_CFI_1/2023
EntscheidungsreferenzORD_2233/2024
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 5

1 Central Division (Section Munich) UPC_CFI_1/2023 Procedural Order and Information on Next Steps of the Court of First Instance of the Unified Patent Court delivered on 24/01/2024 RELEVANT PROCEEDING PARTIES 1) Sanofi-Aventis Deutschland GmbH (Claimant) - Brüningstrasse 50 - 65926 - Frankfurt - DE Represented by Daniel Wise, Agathe Michel-de Cazotte 2) Sanofi-Aventis Groupe (Claimant) - 82 Avenue Raspail - 94250 - Gentilly - FR Represented by Daniel Wise, Agathe Michel-de Cazotte 3) Sanofi Winthrop Industrie S.A. (Claimant) - 82 Avenue Raspail - 94250 - Gentilly - FR Represented by Daniel Wise, Agathe Michel-de Cazotte 2 4) Amgen, Inc. (Defendant) - One Amgen Center Drive - CA 91320-1799 - Thousand Oaks - US Represented by Koen Bijvank PATENT AT ISSUE Patent no. Proprietor/s EP3666797 Amg ...